A Multicenter, Relapse Prevention Study With Levomilnacipran Extended Release (ER) in Participants With Major Depressive Disorder

NCT02288325 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

644

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder, Major

Interventions

DRUG: Levomilnacipran ER
DRUG: Placebo

Sponsor

Forest Laboratories